Tag: Chemotherapy
Intervention Improves Cognitive Symptoms in Cancer Survivors
Cognitive rehabilitation program can improve self-reported cognitive function through six months
Genetic Testing May Help ID VTE Risk in Breast Cancer Patients
Older breast cancer patients with increased genetic susceptibility receiving chemo have highest risk
Costs of Chemo for Breast Cancer Vary Widely in the United States
Lower-priced options could save patients thousands of dollars, researchers say
TP53, MDM2 Alterations Linked to Cisplatin Resistance in GCT
TP53, MDM2 alterations predict adverse prognosis in patients with germ cell tumors
Neoadjuvant Chemotherapy Use Up in Ovarian Cancer Treatment
NACT use up from 2003 to 2012; linked to shorter overall survival in stage IIIC but not stage IV disease
Pregnancy Screens Lacking for Teens With Leukemia
Low rates for teens with acute leukemia and ER visits before teratogenic exposures
Dexrazoxane Prevents Chemo-Induced Cardiotoxicity
Dexrazoxane beneficial for preventing anthracycline-induced cardiotoxicity in children, young adults
Recs Developed for Neoadjuvant Chemo in Ovarian Cancer
Guidance provided for clinicians treating women with stage IIIC or IV epithelial ovarian cancer
Increasing Cumulative Cisplatin Dose Linked to Hearing Loss
Severe to profound hearing loss seen in 18 percent of male germ cell tumor survivors
Candesartan Doesn’t Prevent Trastuzumab Cardiotoxicity
Cumulative incidence of cardiac events not significantly different with candesartan, placebo
